ReviewNeurotrauma reports
The Neuroimmune Nexus: Diet-Induced Obesity, Inflammation, and Diet-Modulated Recovery Following Traumatic Brain Injury.
Review in Neurotrauma reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traumatic brain injury (TBI) is a prevalent chronic disorder associated with progressive neurological decline. Due to the highly heterogeneous nature of TBI, treatment and care pose a significant challenge. Recent developments in the multidimensional classification framework of TBI suggest that patient-related factors (e.g., sex, age, and medical history, including body weight and pre-existing comorbidities) and injury-related factors (e.g., comorbid extracranial injury, secondary insults, and injury mechanism) need to be taken into consideration for the development of targeted treatment strategies and comprehensive care for TBI patients. To this end, there is now a substantial body of evidence that body weight and pre-existing obesity may be a critical, yet modifiable, patient-related factor associated with worsened TBI outcomes. It is hypothesized that obesity is characterized by a state of chronic low-grade systemic inflammation that primes both peripheral and central immune responses, rendering the individual particularly vulnerable to the negative consequences of TBI. In contrast, specific dietary patterns such as the Mediterranean diet, ketogenic diet, and dietary restriction may attenuate inflammatory processes and exert neuroprotective effects on TBI outcomes. In this review, we synthesize pre-clinical and clinical evidence highlighting the complex relationship between diet and TBI outcomes. We explore how obesity-induced peripheral inflammation may serve as a viable target to alleviate negative outcomes in TBI subpopulations with pre-existing metabolic dysfunction. In addition, we discuss how modification of dietary patterns may serve as a clinically relevant, non-pharmacological strategy to reduce the negative sequelae of events following exposure to TBI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.